Regional News

Astravolt Unveils "Active Intelligence" Strategy at Silicon Valley Launch

From Portable Power to Connected Community Ecosystems: A Vision for All- Scenario Intelligent Energy SAN JOSE, Calif., Feb. 6, 2026 /PRNewswire/ -- Astravolt, an intelligent energy technology company, formally entered the North American market today with a comprehensive vision for an "all-scenari...

2026-02-07 01:00 837

Beyond Games and Chatbots: Bonzu Defines a New Species of AI Companionship

More than conversation — building "exclusive memories" through shared adventures HONG KONG, Feb. 6, 2026 /PRNewswire/ -- Bonzu, a new species of AI companionship, is scheduled to launch soon. The Birth of a New Species While the world debates AI's impact on the workforce, millions are quietly f...

2026-02-06 23:00 1091

Neurophet Secures FDA 510(k) Clearance for "Neurophet AQUA AD Plus," Marking Its Third U.S. Regulatory Milestone

* Following AQUA and SCALE PET, the latest FDA clearance reinforces Neurophet's leadership in AI-based Alzheimer's disease imaging analysis * Advanced analysis of neuroimaging features associated with cerebral microbleeds and edema supports imaging-based clinical decision-making and accelera...

2026-02-06 22:00 1865

Hape and The Metropolitan Museum of Art Unveil Art-Inspired Toy Collection at New York Toy Fair 2026

Blending world-renowned art with early learning, the collaboration invites children to explore creativity through play NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Following their initial collaboration announcement last year, Hape Toys and The Metropolitan Museum of Art today ...

2026-02-06 22:00 1203

The domestic service industry will continue to be exempt from value-added tax, and the 2026 tax reform will promote the sustainable and high-quality development of China's domestic service sector

FUZHOU, China, Feb. 6, 2026 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider inChina, announced today that the company will fully leverage new tax incentives to enhance financial management, strengthen trainin...

2026-02-06 21:30 1837

Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology

CAMBRIDGE, Mass., Feb. 6, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico")  (3696.HK),  a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced the appointment ofHalle Zhang, PhD (Med), as Vice President, Clinical Development – Oncology. Dr. Z...

2026-02-06 21:00 1893

Samsung Biologics leads climate transparency with independent validation of Product Carbon Footprint system

* Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards * Validation reflects continued efforts to establish credible carbon accounting in support of net-zero goals * Validated system provides reliable, consistent carbon footprint data for clients I...

2026-02-06 21:00 2191

MicroCloud Hologram Inc. Develops GHZ State and W State Transmission Scheme Based on Brownian State Quantum Channel

SHENZHEN, China, Feb. 6, 2026 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, developed a transmission scheme for GHZ states and W states based on Brownian state quantum channels. This scheme establishes an efficient transmission ...

2026-02-06 21:00 2076

Delonix Bioworks Announces IND Clearance for DX-104, a Novel Engineered MenB OMV Vaccine Candidate, in China and Australia

SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines,recently announced that its Group B meningococcal (MenB) vaccine candidate, DX-104, has received Investigational New Drug (IND) clearance fromChina's Natio...

2026-02-06 20:00 1856

LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders

BEIJING, Feb. 6, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics fo...

2026-02-06 20:00 2226

Aucta Pharmaceuticals, Inc. ("Aucta Pharmaceuticals") prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line

BASKING RIDGE, N.J., Feb. 6, 2026 /PRNewswire/ -- Aucta Pharmaceuticals is pleased to announce the late January launch of PYQUVI oral suspension 22.75 mg/mL.  PYQUVI, a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older, is bioequi...

2026-02-06 19:59 1597

Western Leaders' Visits to China Gather Pace: in Search of New Hope

BEIJING, Feb. 6, 2026 /PRNewswire/ -- A news report from China.org.cn on the wave of high-level interactions betweenChina and Western countries in recent weeks:   Western Leaders’ Visits to China Gather Pace: in Search of New Hope First Canada, then Finland, followed by the ...

2026-02-06 17:23 1490

Appotronics Wins Best of Show Award at ISE 2026: Redefining AV Technology

Best of Show Award: Redefining AV Technology BARCELONA, Spain, Feb. 6, 2026 /PRNewswire/ -- Appotronics, a global leader in laser display technology, announced that its product has been honored with the 2026 ISE Best of Show Award in the AV Technology category. Selected and presented by Future's...

2026-02-06 17:03 1580

Shanghai lights up Times Square with Chinese New Year greeting

SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- A news report from english.shanghai.gov.cn The Nasdaq screen at Times Square, New York, broadcasts a special video produced by International Services Shanghai on Feb 2, sh...

2026-02-06 16:37 1776

Wanxiang A123 Ends the Era of Thermal Runaway with Semi-Solid-State and Immersion Cooling Technologies

With nearly 50 energy storage fires reported globally in the past year, thermal runaway has emerged as the industry's most critical safety challenge. DETROIT, Feb. 6, 2026 /PRNewswire/ -- Wanxiang A123 Systems Corp. unveiled a next-generation safety solution at its"Gathering Stars, Smart Storage ...

2026-02-06 15:58 1815

PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101

SEONGNAM, South Korea, Feb. 6, 2026 /PRNewswire/ -- PharmaResearch Co., Ltd. (CEO:Jihoon Sohn) today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for PRD-101, enabling the initiation of a Phase 1 clinical trial inthe United ...

2026-02-06 15:20 1770

Japonisme Reignites in Tokyo's Mukojima: A New Cultural Experience Invites Visitors to Walk, Print, and Take Home the World of Hokusai

– Experience Edo Culture with All Five Senses through an Ukiyo-e Walking Tour, Woodblock Printing Workshop, and Artisan Studio Shopping – TOKYO, Feb. 5, 2026 /PRNewswire/ -- A new cultural tourism program titled "Ukiyo-e Guided Walking Tour + Woodblock Printing Experience and Artisan Studio ...

2026-02-06 15:12 1679

Images over two decades: From Yixian to the world

BEIJING, Feb. 6, 2026 /PRNewswire/ -- This is a report from China.org.cn:   When a beam of light travels through Yixian county for 20 years, what does it illuminate? It lights up moments captured by Associated Press contract photographer Dan Sandoval in Xidi village: beneat...

2026-02-06 15:06 1449

TIER IV selected for ATLA-led study exploring autonomous driving applications for SDF facilities

TOKYO, Feb. 4, 2026 /PRNewswire/ -- TIER IV , the pioneering force behind open-source software for autonomous driving, has been selected for an Acquisition, Technology and Logistics Agency (ATLA) study assessing autonomous vehicle applications for Japan Self-Defense Forces (...

2026-02-06 13:51 2880

Akeso Receives Fifth Breakthrough Therapy Designation from NMPA for Ivonescimab in First-Line Treatment of Advanced Biliary Tract Cancer

HONG KONG, Feb. 5, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody targeting PD-1 and VEGF, has been granted its fifth Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of the National Medic...

2026-02-06 10:26 2321
12345 ... 1677